These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 4447926

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An exponential model relating censored survival data and concomitant information for prostatic cancer patients.
    Byar DP, Huse R, Bailar JC.
    J Natl Cancer Inst; 1974 Feb; 52(2):321-6. PubMed ID: 4856154
    [No Abstract] [Full Text] [Related]

  • 4. [Rate of survival in prostatic cancer with bone metastasis].
    Kuntz D, Ryckewaert A.
    Rev Fr Etud Clin Biol; 1969 Feb; 14(6):609-13. PubMed ID: 5824263
    [No Abstract] [Full Text] [Related]

  • 5. Endocrine treatment of cancer of the prostate.
    Madsen PO, Pedersen JF, Knuth OE.
    Wis Med J; 1970 Jul; 69(7):177-81. PubMed ID: 4916084
    [No Abstract] [Full Text] [Related]

  • 6. Current status of bilateral adrenalectomy or advanced prostatic carcinoma.
    Bhanalaph T, Varkarakis MJ, Murphy GP.
    Ann Surg; 1974 Jan; 179(1):17-23. PubMed ID: 4817870
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Importance of serum acid phosphatase for the prognosis of prostatic carcinoma].
    Breitwieser P, Nöske HD.
    Z Urol Nephrol; 1971 Apr; 64(4):249-56. PubMed ID: 5094006
    [No Abstract] [Full Text] [Related]

  • 9. Biologic and pathophysiologic prognosticating indices in prostatic cancer.
    Madduri SD, Sporer A, Seebode JJ.
    Am Surg; 1978 May; 44(5):290-5. PubMed ID: 666117
    [No Abstract] [Full Text] [Related]

  • 10. [Prognosis and treatment of prostatic carcinoma].
    Klug W.
    Zentralbl Chir; 1968 Mar 09; 93(10):362-6. PubMed ID: 5674208
    [No Abstract] [Full Text] [Related]

  • 11. Orchiectomy for advanced prostatic carcinoma. A reevaluation.
    Blackard CE, Byar DP, Jordan WP.
    Urology; 1973 Jun 09; 1(6):553-60. PubMed ID: 4588820
    [No Abstract] [Full Text] [Related]

  • 12. Prostatic carcinoma treated at categorical center: clinical and pathologic observations.
    Schoonees R, Palma LD, Gaeta JF, Moore RH, Murphy GP.
    N Y State J Med; 1972 May 01; 72(9):1021-7. PubMed ID: 4502386
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cancer of the prostate.
    N Engl J Med; 1968 Apr 11; 278(15):848-9. PubMed ID: 5642506
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prognosis of prostatic cancer.
    Arvola I, Lilius HG, Uusi-Penttilä S.
    Ann Chir Gynaecol Fenn; 1972 Apr 11; 61(1):25-9. PubMed ID: 5021539
    [No Abstract] [Full Text] [Related]

  • 17. Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate.
    Blackard CE, Doe RP, Mellinger GT, Byar DP.
    Cancer; 1970 Aug 11; 26(2):249-56. PubMed ID: 4916019
    [No Abstract] [Full Text] [Related]

  • 18. Prostatic adenocarcinoma of ductal origin.
    Dube VE, Farrow GM, Greene LF.
    Cancer; 1973 Aug 11; 32(2):402-9. PubMed ID: 4124700
    [No Abstract] [Full Text] [Related]

  • 19. [Prostatic cancer: indications for hormone therapy].
    Bruntsch U, Gallmeier WM.
    MMW Munch Med Wochenschr; 1979 Mar 02; 121(9):300-2. PubMed ID: 85258
    [No Abstract] [Full Text] [Related]

  • 20. [Advanced prostatic cancer: therapeutic modalities].
    Faul P, Altwein JE.
    Dtsch Med Wochenschr; 1984 Dec 21; 109(51-52):1975-80. PubMed ID: 6391887
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.